TXNDC5 and neoplasm: The inactivation or downregulation of nuclear receptor 4A1 (NR4A1) downregulates TXNDC5, isocitrate dehydrogenase 1, and the mTOR (mammalian target of rapamycin) pathway, further promoting ROS generation, inducing apoptosis, and inhibiting tumor growth [214,215,216].